SERPINE1 and breast carcinoma: PAI-1-targeting miR-30b is predictive of the chemotherapy response in breast cancer [81], whereas PAI-1-targeting miR-486-5p has been proposed as a potential diagnostic biomarker in NSCLC [82] and miR-34a and miR-143 in osteosarcoma [83].